Stoppa-Lyonnet D - Search Results

1

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.

Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.

2

Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D, Sobol H. Eisinger F, et al. Cancer Res. 1996 Feb 1;56(3):471-4. Cancer Res. 1996. PMID: 8564955

3

Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.

Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Peyrat JP, Kerangueven F, Janin N, Noguchi T, Eisinger F, Guinebretiere JM, Jacquemier J, Birnbaum D. Sobol H, et al. Cancer Res. 1996 Jul 15;56(14):3216-9. Cancer Res. 1996. PMID: 8764110

4

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pagès S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Bonaïti-Pellié C, Thomas G. Stoppa-Lyonnet D, et al. Am J Hum Genet. 1997 May;60(5):1021-30. Am J Hum Genet. 1997. PMID: 9150149 Free PMC article.

5

Mutations at BRCA1: the medullary breast carcinoma revisited.

Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de Paillerets B, Peyrat JP, Longy M, Guinebretière JM, Sauvan R, Noguchi T, Birnbaum D, Sobol H. Eisinger F, et al. Cancer Res. 1998 Apr 15;58(8):1588-92. Cancer Res. 1998. PMID: 9563465

6

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

Ansquer Y, Gautier C, Fourquet A, Asselain B, Stoppa-Lyonnet D. Ansquer Y, et al. Lancet. 1998 Aug 15;352(9127):541. doi: 10.1016/s0140-6736(05)79248-5. Lancet. 1998. PMID: 9716060 No abstract available.

7

Genetic testing for breast cancer predisposition.

Gauthier-Villars M, Gad S, Caux V, Pagès S, Blandy C, Stoppa-Lyonnet D. Gauthier-Villars M, et al. Surg Clin North Am. 1999 Oct;79(5):1171-87, xxi. doi: 10.1016/s0039-6109(05)70067-0. Surg Clin North Am. 1999. PMID: 10572557 Review.

8

Low expression of bcl-2 in Brca1-associated breast cancers.

Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X. Freneaux P, et al. Br J Cancer. 2000 Nov;83(10):1318-22. doi: 10.1054/bjoc.2000.1438. Br J Cancer. 2000. PMID: 11044356 Free PMC article.

9

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelénat H, Pouillart P, Vincent-Salomon A, Fourquet A, Asselain B. Stoppa-Lyonnet D, et al. J Clin Oncol. 2000 Dec 15;18(24):4053-9. doi: 10.1200/JCO.2000.18.24.4053. J Clin Oncol. 2000. PMID: 11118466

10

Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.

Pages S, Caux V, Stoppa-Lyonnet D, Tosi M. Pages S, et al. Br J Cancer. 2001 Feb;84(4):482-8. doi: 10.1054/bjoc.2000.1627. Br J Cancer. 2001. PMID: 11207042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

488 results

Search Page